[Possibilities of preventing and combating congenital toxoplasmosis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000209:etiology; D002825:Chorioretinitis / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D001523:Mental Disorders / Q000209:etiology; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014125:Toxoplasmosis, Congenital / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D013411:Sulfadiazine; D011739:Pyrimethamine
Posibilităţile de prevenire şi combatere a toxoplasmozei congenitale.